Related references
Note: Only part of the references are listed.Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu et al.
NATURE MEDICINE (2021)
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W. Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
SP1/TGF-β1/SMAD2 pathway is involved in angiogenesis during osteogenesis
Ao Ding et al.
MOLECULAR MEDICINE REPORTS (2020)
Mouse models of colorectal cancer: Past, present and future perspectives
Florian Buertin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification
Yong Chen et al.
FRONTIERS IN MEDICINE (2020)
Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers
Tsuyoshi Ozawa et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
Natural products against renin-angiotensin system for antifibrosis therapy
Tian Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
Yanxia Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM CNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
Toshiaki Watanabe et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
New insights into TGF-β/Smad signaling in tissue fibrosis
He-He Hu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
The role of TGF-beta/SMAD4 signaling in cancer
Ming Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Treatment of hypertension: The ESH/ESC guidelines recommendations
Cesare Cuspidi et al.
PHARMACOLOGICAL RESEARCH (2018)
Bevacizumab-induced hypertension: Clinical presentation and molecular understanding
Megan Li et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B
Sameh Saber et al.
TOXICOLOGY LETTERS (2018)
Capillary pericytes express α-smooth muscle actin, which requires prevention of filamentous-actin depolymerization for detection
Luis Alarcon-Martinez et al.
ELIFE (2018)
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
Blanaid M. Hicks et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary
Luigi Tarantini et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2017)
Systemic Management of Colorectal Cancer
Wells A. Messersmith
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Novel anti-angiogenic therapeutic strategies in colorectal cancer
M. Tampellini et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
KARDIOLOGIA POLSKA (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
Nuh N. Rahbari et al.
Science Translational Medicine (2016)
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis
Yi-Ning Dai et al.
CANCER CAUSES & CONTROL (2015)
Current controversies in the management of metastatic colorectal cancer
Ruth Vera et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients
Hiroki Osumi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
Collagen Signaling Enhances Tumor Progression after Anti-VEGF Therapy in a Murine Model of Pancreatic Ductal Adenocarcinoma
Kristina Y. Aguilera et al.
CANCER RESEARCH (2014)
VEGFA, FLT1, KDR and Colorectal Cancer: Assessment of Disease Risk, Tumor Molecular Phenotype, and Survival
Martha L. Slattery et al.
MOLECULAR CARCINOGENESIS (2014)
VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
Rucheng Yao et al.
ONCOLOGY LETTERS (2014)
Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
Asmaa E. El-Kenawi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Jonathan Welti et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Combining two strategies to improve perfusion and drug delivery in solid tumors
Triantafyllos Stylianopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan et al.
NATURE COMMUNICATIONS (2013)
TGF-beta signalling in colon carcinogenesis
Pavlos Lampropoulos et al.
CANCER LETTERS (2012)
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies
Patrizia Ferroni et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
Matrix rigidity regulates a switch between TGF-β1-induced apoptosis and epithelial-mesenchymal transition
Jennifer L. Leight et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
Bevacizumab-Induced Hypertension Pathogenesis and Management
Kostas N. Syrigos et al.
BIODRUGS (2011)
Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion
Vivien J. Coulson-Thomas et al.
CELL AND TISSUE RESEARCH (2011)
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324168 participants from randomised trials
Sripal Bangalore et al.
LANCET ONCOLOGY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
Iike Sipahi et al.
LANCET ONCOLOGY (2010)
Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads
Annamaria Rapisarda et al.
CELL CYCLE (2009)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients
Y Yonenaga et al.
ONCOLOGY (2005)
Hyaluronan mediates adhesion of metastatic colon carcinoma cells
C Laurich et al.
JOURNAL OF SURGICAL RESEARCH (2004)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Expression of hyaluronate and hyaluronate synthase in human primary tumours an their metastases in scid mice
M Jojovic et al.
CANCER LETTERS (2002)
Share Paper
